Skip to main content

Information Management Unit (UGI)

The Information Management Unit (UGI) provides support to the clinical departments and management of the Institut Bordet.

The UGI carries out 4 particular missions:

  • An epidemiology mission – by developing, managing and operating the hospital Cancer Register and by incorporating into it data from multidisciplinary oncological consultations. In so doing it contributes actively to the Belgian Cancer Register and makes the hospital Cancer Register available as a research support and care quality evaluation tool.
  • An analysis and reporting mission in relation to the Institut’s activities, in particular by developing and maintaining a data warehouse.
  • An oncological clinical research mission in terms of methodology and statistics (single-centre and multicentre research, centralised at the Institut Bordet and elsewhere).
  • A website maintenance mission for the Institut Bordet.

Research projects

The UGI collaborates on many research projects at the request of the Institut Bordet clinical departments and of multicentre groups. It also develops its own projects, including:
  

Project 1

Identification and recording of relapse events in the Cancer Register

Our team

Coordination
Marianne Paesmans, director (actuary)

The team
Iraida Agaeva, data manager
Lieveke Ameye, statistician
Sylvie Berckmans, data manager

Alain Barbason, analyst data warehouse
Laurent Dubreucq, data manager
Aline Kayumba, data manager
Laetitia Martins, data manager

Michel Moreau, epidemiologist
Bernard Schenk, data warehouse officer
Louise Vanderweerden, webmaster and secretariat

 Scientific publications

Clinical outcomes of laryngopharyngeal reflux treatment: A systematic review and meta-analysis.

Authors : Lechien JR, Saussez S, Schindler A, Karkos PD, Hamdan AL, Harmegnies B, De Marrez LG, Finck C, Journe F, Paesmans M, Vaezi MF
Year : 2019
Journal : Laryngoscope
Volume : 129
Pages : 1174-1187

Predictive factors for cancer-associated thrombosis in a large retrospective single-center study.

Authors : Haltout J, Awada A, Paesmans M, Moreau M, Klastersky J, Machiels G, Ignatiadis M, Kotecki N
Year : 2019
Journal : Support Care Cancer
Volume : 27
Pages : 1163-1170

Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.

Authors : Charette N, Vandeputte C, Ameye L, Bogaert CV, Krygier J, Guiot T, Deleporte A, Delaunoit T, Geboes K, Van Laethem JL, Peeters M, Demolin G, Holbrechts S, Flamen P, Paesmans M, Hendlisz A
Year : 2019
Journal : BMC Cancer
Volume : 19
Pages : 134

Combining 18F-FDG PET/CT-based Metabolically Active Tumor Volume and Circulating Cell-free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer.

Authors : Woff E, Kehagias P, Vandeputte C, Ameye L, Guiot T, Paesmans M, Hendlisz A, Flamen P
Year : 2019
Journal : J Nucl Med

[Lung cancer: Prognosis in intensive care depends mainly on the acute complication].

Authors : Gorham J, Ameye L, Paesmans M, Berghmans T, Sculier JP, Meert AP
Year : 2019
Journal : Rev Mal Respir

Follow us!

Support research

Support research

Research at the Institut Jules Bordet depends on your generosity. Make a donation today and join us in the fight against cancer.

Learn more